Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
---|---|---|---|---|---|---|---|---|---|---|---|---|
CCRN | CROSS COUNTRY HEALTHCARE INC | $557.08M | $1.78B | $90.52M | $45.89M | $1.32 | -32.73% | 17.26% | -68.87% | N/A | 2024-05-14 | |
SMLR | SEMLER SCIENTIFIC INC | $194.55M | $68.18M | $24.70M | $20.58M | $3.06 | 20.28% | 25.98% | 43.66% | 30.13% | 2024-05-07 | |
PGNY | PROGYNY INC | $3.13B | $1.09B | $69.67M | $62.04M | $0.65 | 38.34% | 59.52% | 96.97% | 74.65% | 2024-05-23 | |
CORT | CORCEPT THERAPEUTICS INC | $2.50B | $523.53M | $122.89M | $117.19M | $1.15 | 26.51% | 15.17% | 30.68% | 11.75% | 2024-05-17 | |
INCY | INCYTE CORP | $12.14B | $3.77B | $1.11B | $745.44M | $3.33 | 8.58% | 13.53% | 128.08% | 22.65% | 2024-06-12 | |
AMLX | AMYLYX PHARMACEUTICALS INC | $134.89M | $380.79M | $55.39M | $49.27M | $0.73 | 1,612.94% | N/A | N/A | N/A | 2024-06-06 | |
HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.75B | $617.51M | $237.47M | $137.70M | $2.35 | 30.92% | N/A | -26.33% | N/A | 2024-05-29 | |
INMD | INMODE LTD | $1.58B | $466.26M | $199.66M | $181.11M | $2.17 | -1.72% | 33.54% | 4.33% | 34.66% | ||
PBYI | PUMA BIOTECHNOLOGY INC | $222.86M | $226.63M | $41.45M | $15.38M | $0.33 | -3.59% | -4.38% | 230.00% | N/A | 2024-06-18 | |
MOH | MOLINA HEALTHCARE INC | $20.11B | $35.85B | $1.72B | $1.07B | $18.55 | 10.82% | 14.32% | 24.92% | 7.45% | ||
GILD | GILEAD SCIENCES INC | $81.65B | $27.12B | $10.55B | $5.67B | $4.54 | -0.60% | 4.15% | 24.04% | 1.57% | 2024-06-12 | |
JNJ | JOHNSON & JOHNSON | $357.58B | $81.80B | $49.47B | $38.48B | $15.26 | 5.60% | 0.05% | 215.29% | 22.73% | 2024-05-29 | |
NBIX | NEUROCRINE BIOSCIENCES INC | $14.26B | $1.98B | $497.00M | $369.70M | $3.77 | 23.99% | 30.76% | 462.69% | N/A | ||
LNTH | LANTHEUS HOLDINGS INC | $5.23B | $1.37B | $674.08M | $460.53M | $6.74 | 32.98% | 31.50% | N/A | 43.70% | ||
BMRN | BIOMARIN PHARMACEUTICAL INC | $15.59B | $2.47B | $359.85M | $205.46M | $1.09 | 13.74% | 10.23% | 194.59% | N/A | 2024-05-21 | |
VYGR | VOYAGER THERAPEUTICS INC | $485.45M | $250.01M | $126.46M | $132.33M | $3.08 | 511.16% | 101.01% | N/A | N/A | 2024-05-13 | |
PCRX | PACIRA BIOSCIENCES INC | $1.23B | $674.98M | $157.58M | $41.96M | $0.91 | 1.22% | 14.88% | 160.00% | N/A | 2024-06-11 | |
SIGA | SIGA TECHNOLOGIES INC | $738.64M | $139.92M | $88.31M | $68.07M | $0.95 | 26.31% | -21.75% | 106.52% | -29.04% | 2024-05-07 | |
UTHR | UNITED THERAPEUTICS CORP | $11.56B | $2.50B | $1.49B | $1.05B | $22.36 | 26.09% | 9.30% | 40.98% | N/A | 2024-06-25 | |
EXEL | EXELIXIS INC | $6.38B | $1.85B | $312.76M | $205.05M | $0.64 | 10.98% | 16.63% | 33.33% | -21.67% | 2024-05-30 | |
AMPH | AMPHASTAR PHARMACEUTICALS INC | $2.05B | $644.40M | $225.48M | $137.55M | $2.85 | 29.14% | 16.94% | 51.60% | N/A | 2024-06-03 | |
SEM | SELECT MEDICAL HOLDINGS CORP | $4.18B | $6.79B | $773.70M | $269.58M | $2.10 | 6.08% | 5.67% | 47.89% | 14.44% | ||
CNC | CENTENE CORP | $40.10B | $155.52B | $5.67B | $2.74B | $5.08 | 6.34% | 18.93% | 88.15% | 13.73% | 2024-05-14 | |
HALO | HALOZYME THERAPEUTICS INC | $5.18B | $829.25M | $451.95M | $281.59M | $2.13 | 25.62% | 40.43% | 43.92% | N/A | 2024-05-07 | |
GMAB | GENMAB A | $19.20B | $2.56B | N/A | $784.32M | $1.20 | 15.36% | 42.16% | 3.78% | 29.55% | ||
ASTH | ASTRANA HEALTH INC | $2.12B | $1.39B | $133.74M | $60.72M | $1.30 | 21.19% | 21.68% | 30.00% | 31.55% | 2024-05-07 | |
WST | WEST PHARMACEUTICAL SERVICES INC | $26.70B | $2.93B | $833.50M | $568.70M | $7.67 | 1.56% | 10.91% | 3.51% | 20.98% | 2024-05-14 | |
MDT | MEDTRONIC PLC | $108.56B | $32.32B | $8.88B | $4.20B | $3.15 | 5.03% | 1.13% | 3.28% | -2.90% | 2024-05-23 | |
MCK | MCKESSON CORP | $70.09B | $301.51B | $4.53B | $3.00B | $22.24 | 10.08% | 7.15% | 1.23% | N/A | 2024-05-07 | |
ROIV | ROIVANT SCIENCES LTD | $9.35B | $123.24M | $4.58B | $4.47B | $5.56 | 185.76% | N/A | N/A | N/A | 2024-06-26 | |
STAA | STAAR SURGICAL CO | $2.25B | $322.42M | $31.83M | $21.35M | $0.44 | 13.37% | 21.07% | -46.99% | 29.67% | ||
RPRX | ROYALTY PHARMA PLC | $17.02B | $2.35B | $1.32B | $1.13B | $2.54 | 5.24% | 5.58% | 2,440.00% | N/A | 2024-06-06 | |
NSYS | NORTECH SYSTEMS INC | $41.60M | $139.33M | $8.00M | $6.87M | $2.53 | 3.88% | 4.21% | 237.33% | 111.35% | 2024-05-16 | |
COLL | COLLEGIUM PHARMACEUTICAL INC | $1.18B | $566.77M | $308.33M | $48.16M | $1.43 | 22.17% | 15.11% | N/A | N/A | 2024-05-09 | |
CVS | CVS HEALTH CORP | $70.26B | $360.94B | $12.63B | $7.32B | $5.71 | 9.07% | 11.39% | 80.70% | N/A | ||
OSUR | ORASURE TECHNOLOGIES INC | $405.88M | $405.47M | $77.19M | $53.66M | $0.73 | 4.64% | 17.41% | N/A | 17.21% | 2024-05-08 | |
SLP | SIMULATIONS PLUS INC | $963.47M | $64.67M | $16.85M | $10.52M | $0.53 | 18.86% | 15.66% | 1.92% | 4.27% | 2024-07-04 | |
AMN | AMN HEALTHCARE SERVICES INC | $2.27B | $3.79B | $500.98M | $210.68M | $5.38 | -27.73% | 12.15% | -45.98% | 12.47% | 2024-05-09 | |
ZBH | ZIMMER BIOMET HOLDINGS INC | $24.80B | $7.45B | $2.16B | $963.90M | $4.64 | 4.85% | -1.14% | 117.84% | N/A | ||
CHE | CHEMED CORP | $8.65B | $2.29B | $427.54M | $283.41M | $18.78 | 5.96% | 4.90% | 16.94% | 7.95% | 2024-05-20 | |
UTMD | UTAH MEDICAL PRODUCTS INC | $249.04M | $50.22M | $26.46M | $16.64M | $4.58 | -3.93% | 3.64% | 1.10% | -1.62% | ||
COR | CENCORA INC | $44.69B | $276.54B | $2.97B | $1.85B | $9.24 | 11.71% | 9.56% | 17.26% | 16.32% | ||
HUM | HUMANA INC | $38.47B | $109.24B | $4.20B | $1.99B | $16.29 | 14.22% | 13.21% | -34.29% | 4.84% | 2024-05-14 | |
VEEV | VEEVA SYSTEMS INC | $32.77B | $2.36B | $632.34M | $525.71M | $3.27 | 9.68% | 22.35% | 4.14% | 15.51% | 2024-06-12 | |
VMD | VIEMED HEALTHCARE INC | $319.11M | $194.05M | $38.50M | $10.33M | $0.27 | 32.79% | 23.16% | 80.00% | 3.26% | ||
ADUS | ADDUS HOMECARE CORP | $1.59B | $1.06B | $106.56M | $62.52M | $3.91 | 11.31% | 15.43% | 34.83% | 23.52% | ||
MEIP | MEI PHARMA INC | $21.32M | $72.65M | $21.69M | $19.84M | $2.97 | 16.10% | 83.24% | N/A | N/A | 2024-05-09 | |
CAH | CARDINAL HEALTH INC | $24.01B | $220.57B | $1.70B | $552.00M | $2.28 | 11.03% | 8.97% | 31.79% | 66.16% | ||
HCM | HUTCHMED (CHINA) LTD | $3.45B | $838.00M | N/A | $100.78M | $0.60 | 96.52% | 31.38% | N/A | N/A | 2024-05-13 | |
ALGN | ALIGN TECHNOLOGY INC | $21.63B | $3.92B | $839.46M | $462.28M | $6.08 | 5.72% | 13.51% | 50.12% | 5.28% | 2024-05-22 | |
TGTX | TG THERAPEUTICS INC | $2.55B | $289.33M | $53.85M | $41.20M | $0.29 | 3,275.73% | 352.80% | N/A | N/A | ||
DXCM | DEXCOM INC | $51.56B | $3.80B | $991.00M | $639.30M | $1.65 | 25.78% | 27.51% | 117.11% | N/A | 2024-05-22 | |
KMDA | KAMADA LTD | $328.21M | $142.52M | $22.44M | $8.28M | $0.17 | 10.19% | 4.48% | N/A | -20.93% | 2024-05-08 | |
SNY | SANOFI | $124.79B | $49.94B | $14.09B | $5.81B | $2.32 | 6.87% | 4.70% | -32.73% | 3.84% | ||
PRVA | PRIVIA HEALTH GROUP INC | $2.26B | $1.66B | $29.23M | $23.08M | $0.20 | 22.19% | 20.31% | N/A | N/A | 2024-05-09 | |
HSIC | HENRY SCHEIN INC | $8.81B | $12.34B | $871.00M | $416.00M | $3.18 | -2.44% | 5.55% | -19.49% | -1.96% | 2024-05-07 | |
LMAT | LEMAITRE VASCULAR INC | $1.68B | $193.48M | $48.99M | $30.11M | $1.36 | 19.69% | 12.88% | 44.68% | 2.88% | ||
AZN | ASTRAZENECA PLC | $234.88B | $47.61B | $14.25B | $6.33B | $2.05 | 8.60% | 16.27% | 34.98% | 16.57% | 2024-06-27 | |
IRMD | IRADIMED CORP | $552.03M | $67.69M | $23.44M | $17.92M | $1.42 | 19.87% | 16.33% | 30.28% | 15.87% | 2024-06-14 | |
PODD | INSULET CORP | $12.33B | $1.70B | $323.60M | $206.30M | $2.96 | 30.02% | 24.66% | 4,128.57% | 118.09% | 2024-05-22 | |
ZYXI | ZYNEX INC | $341.27M | $188.68M | $17.98M | $8.17M | $0.22 | 11.48% | 40.68% | -51.11% | -4.23% | 2024-05-16 | |
ABT | ABBOTT LABORATORIES | $183.77B | $40.33B | $10.41B | $5.63B | $3.23 | -2.84% | 5.59% | -2.42% | 16.74% | ||
UNH | UNITEDHEALTH GROUP INC | $455.79B | $371.62B | $35.57B | $22.38B | $24.12 | 14.64% | 10.43% | 12.34% | 14.14% | 2024-06-03 | |
BRKR | BRUKER CORP | $9.98B | $2.96B | $659.80M | $427.20M | $2.92 | 17.14% | 9.36% | 46.00% | 20.49% | 2024-05-30 | |
EW | EDWARDS LIFESCIENCES CORP | $51.22B | $6.14B | $1.81B | $1.41B | $2.33 | 11.68% | 9.96% | -3.32% | 13.76% | 2024-05-07 | |
GMED | GLOBUS MEDICAL INC | $6.81B | $1.57B | $290.00M | $122.87M | $1.09 | 53.34% | 17.08% | -42.33% | -7.39% | 2024-05-07 | |
FONR | FONAR CORP | $118.18M | $102.42M | $25.75M | $12.16M | $1.89 | 5.78% | 4.06% | 51.20% | -8.83% | 2024-05-20 | |
NVS | NOVARTIS AG | $199.41B | $49.92B | N/A | $15.25B | $7.41 | 8.81% | 1.48% | 125.91% | 6.77% | 2024-06-20 | |
BIIB | BIOGEN INC | $32.24B | $9.66B | $1.85B | $1.17B | $8.05 | -4.37% | -6.89% | -62.80% | -19.14% | 2024-06-20 | |
ICLR | ICON PLC | $26.06B | $8.23B | $1.62B | $683.12M | $8.30 | 5.29% | 25.44% | 32.80% | 6.18% | ||
LLY | ELI LILLY & CO | $728.66B | $35.93B | $9.13B | $6.14B | $6.82 | 29.76% | 10.69% | 8.08% | 1.57% | ||
MDXG | MIMEDX GROUP INC | $1.05B | $334.51M | $50.76M | $74.16M | $0.52 | 19.20% | -0.41% | N/A | N/A | 2024-06-05 | |
PEN | PENUMBRA INC | $8.19B | $1.06B | $106.91M | $90.95M | $2.37 | 24.95% | 18.93% | N/A | 65.65% | 2024-05-07 | |
PDCO | PATTERSON COMPANIES INC | $2.31B | $6.57B | $384.69M | $193.86M | $2.04 | 2.78% | 3.46% | 0.99% | 19.70% | 2024-06-19 | |
ISRG | INTUITIVE SURGICAL INC | $135.87B | $7.32B | $2.53B | $1.99B | $5.64 | 13.81% | 13.71% | 52.02% | 11.00% | ||
ZTS | ZOETIS INC | $75.72B | $8.73B | $3.72B | $2.39B | $5.19 | 7.91% | 8.11% | 16.89% | 12.50% | 2024-05-22 | |
BTMD | BIOTE CORP | $451.66M | $185.36M | $15.85M | $3.32M | $0.13 | 12.37% | N/A | N/A | N/A | 2024-05-07 | |
VRTX | VERTEX PHARMACEUTICALS INC | $103.97B | $9.87B | $4.61B | $3.62B | $14.05 | 10.51% | 26.49% | 8.33% | 11.26% | ||
REGN | REGENERON PHARMACEUTICALS INC | $105.63B | $13.10B | $4.55B | $3.86B | $36.12 | 5.90% | 21.21% | -7.53% | 9.99% | 2024-06-14 | |
DCGO | DOCGO INC | $385.43M | $624.29M | $27.85M | $6.86M | $0.07 | 41.72% | N/A | -79.41% | N/A | 2024-05-08 | |
VNDA | VANDA PHARMACEUTICALS INC | $278.48M | $192.64M | $9.35M | $2.51M | $0.04 | -24.27% | -0.05% | -63.64% | -39.66% | 2024-05-08 | |
STRR | STAR EQUITY HOLDINGS INC | $14.58M | $45.79M | $26.87M | $23.22M | $1.61 | -19.88% | -15.16% | N/A | 34.19% | 2024-05-13 | |
GSK | GSK PLC | $87.86B | $37.95B | $7.29B | $5.54B | $2.73 | 12.47% | -1.11% | -67.61% | 1.40% | 2024-05-08 | |
TALK | TALKSPACE INC | $537.11M | $150.05M | -$22.01M | -$19.18M | -$0.12 | 25.49% | N/A | N/A | N/A | 2024-05-07 | |
SRPT | SAREPTA THERAPEUTICS INC | $12.76B | $1.40B | $91.13M | $16.90M | $0.41 | 43.83% | 34.11% | N/A | N/A | 2024-06-06 | |
ALC | ALCON INC | $39.66B | $9.46B | $2.25B | $974.00M | $1.98 | 8.47% | 5.74% | 191.18% | N/A | 2024-05-14 | |
MMSI | MERIT MEDICAL SYSTEMS INC | $4.62B | $1.28B | $247.30M | $101.95M | $1.77 | 9.39% | 6.93% | 19.59% | 17.21% | 2024-05-15 | |
DOCS | DOXIMITY INC | $4.59B | $468.33M | $186.53M | $137.63M | $0.72 | 16.58% | N/A | 14.29% | N/A | 2024-05-16 | |
OPCH | OPTION CARE HEALTH INC | $5.22B | $4.43B | $495.02M | $272.67M | $1.53 | 9.59% | 21.82% | 73.86% | N/A | 2024-05-15 | |
TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $337.19M | $276.67M | $24.30M | $28.19M | $1.21 | 7.38% | 12.36% | N/A | 21.87% | ||
CI | CIGNA GROUP | $97.27B | $206.00B | $8.19B | $3.62B | $12.32 | 12.55% | 22.34% | -44.78% | 3.21% | ||
PINC | PREMIER INC | $2.48B | $1.32B | $368.68M | $167.33M | $1.40 | -3.37% | 6.01% | -5.41% | N/A | 2024-05-07 | |
RVTY | REVVITY INC | $12.70B | $2.75B | $1.25B | $693.09M | $5.56 | -16.95% | -0.20% | 23.28% | 20.93% | 2024-05-14 | |
SPOK | SPOK HOLDINGS INC | $290.12M | $140.75M | $26.75M | $16.79M | $0.84 | 5.13% | -3.49% | -48.78% | N/A | ||
CRL | CHARLES RIVER LABORATORIES INTERNATIONAL INC | $12.08B | $4.13B | $1.03B | $474.62M | $9.27 | 3.86% | 12.75% | -3.13% | 14.45% | 2024-05-09 | |
SPRO | SPERO THERAPEUTICS INC | $89.42M | $103.78M | $25.77M | $22.81M | $0.43 | 93.95% | 92.11% | N/A | N/A | 2024-05-29 | |
BNOX | BIONOMICS LIMITED | $11.41M | $14.50k | N/A | -$20.40M | $32.92 | -91.52% | N/A | 261.25% | N/A | ||
STE | STERIS PLC | $20.70B | $5.41B | $1.39B | $566.84M | $5.71 | 13.04% | 14.65% | N/A | 12.35% | 2024-05-08 | |
SCYX | SCYNEXIS INC | $65.31M | $140.14M | $70.89M | $67.04M | $1.40 | 2,652.72% | 252.64% | N/A | N/A | 2024-06-19 | |
BDX | BECTON DICKINSON & CO | $68.37B | $19.72B | $4.36B | $1.32B | $4.54 | 4.82% | 2.97% | -15.46% | 5.83% |
Industry | Stocks | 1d % | 1w % | 1m % | 1y % | Zen Score | P/E ratio | P/B Ratio | ROE | ROA | ROCE | Upside/Downside | Consensus |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
681 | -0.10% | +4.37% | -1.88% | -19.33% | 7.54x | 6.05x | +14.52% | +2.50% | -31.99% | +80.65% | Strong Buy | ||
66 | +0.47% | -0.04% | -3.23% | +1.62% | 38.56x | 4.23x | -23.96% | +6.32% | +11.12% | +10.22% | Buy | ||
17 | +1.17% | +3.14% | +1.61% | +13.48% | 62.48x | 6.25x | +34.40% | +8.36% | +14.55% | +12.50% | Buy | ||
90 | +0.12% | +2.36% | +0.74% | -4.41% | 33.38x | 2.15x | +11.85% | +3.07% | +5.62% | +31.34% | Strong Buy | ||
12 | +0.45% | -0.17% | -0.14% | -1.26% | 19.76x | 2.91x | +19.63% | +6.04% | +14.09% | +16.72% | Buy | ||
61 | +0.60% | +0.75% | -4.68% | -22.85% | 77.05x | 3.26x | +6.62% | +2.09% | +5.12% | +33.92% | Buy | ||
51 | +1.05% | +1.79% | -2.06% | +8.37% | -8.15x | 4.39x | -93.28% | +6.63% | +13.88% | +16.78% | Buy | ||
154 | +0.06% | +2.77% | -1.93% | -11.52% | 27.44x | 3.70x | +10.37% | +5.25% | +7.81% | +19.24% | Buy | ||
9 | +0.61% | -3.39% | -4.05% | +29.02% | 26.18x | 109.61x | -9.15% | +3.48% | +18.94% | +10.35% | Buy | ||
56 | +1.16% | +1.68% | -0.64% | -10.06% | 57.03x | 3.56x | +11.41% | +7.79% | +10.25% | +19.22% | Buy |